EN
RU
(1-Cyano-2-ethoxy-2-oxoethylidenaminooxy)dimethylamino-morpholinocarbenium hexafluorophosphate (COMU) (CAS: 1075198-30-9) is a third-generation, highly efficient coupling reagent extensively utilized in advanced peptide synthesis. Based on the Oxyma scaffold, this premium uronium salt offers superior coupling performance comparable to HATU, while operating as a significantly safer, non-explosive alternative. It effectively minimizes racemization and ensures exceptionally high yields in amide bond formations. Manufactured under rigorous quality control, our industrial-grade COMU provides outstanding batch-to-batch consistency and high solubility, making it an indispensable intermediate for sophisticated active pharmaceutical ingredient (API) development.
Company Name :
Hangzhou GlobalEquipX Information Technology co.,Ltd .Brand :
APIsCNCAS Number :
075198-30-9Industry Standard Abbreviation :
COMU
Product categoriesGlobalEquipX is a professional platform dedicated to the global pharmaceutical industry,
Backed by strong industry expertise, one of our co-founders serves as a strategic advisor to leading pharmaceutical manufacturers and R&D companies in China, including HEC and Menovo, giving us unique insight into market trends and client needs.
With numerous pharmaceutical manufacturers sites, we always ensure consistent quality and sustainable supply.
With over 30 years of proven experiences in import and export in EXP/IMP, we deliver flexible cooperation models and comprehensive one-stop solutions covering API & Intermediate, chemicals, and equipment—helping our clients streamline sourcing and accelerate business growth.
We do hope to have the chance to supply you our sustainable qualified service.
| 13183-79-4 | 5-Mercapto-1-Methyltetrazole | 864731-61-3 | Fluralaner | 68373-14-8 | Sulbactam acid |
| 173334-57-1 | Aliskiren | 54-31-9 | Furosemide | 76497-13-7 | Sultamicillin |
| 73547-70-3 | Ceftazidime dihydrochloride | 1369764-02-2 | Lemborexant | 89786-04-9 | Tazobactam acid |
| 113136-77-9 | Cyclanilide | 1138245-21-2 | Mirogabalin besylate | 2023788-19-2 | Tirzepatide |
| 211427-08-6 | Diquafosol tetrasodium | 186826-86-8 | Moxifloxacin hydrochloride | 1197-18-8 | Tranexamic acid |
| 1229194-11-9 | Edoxaban | 1192491-61-4 | NXL 104 | 2050057-56-0 | Upadacitinib |
| 1210344-83-4 | Ertugliflozin L-pyroglutamic acid | 144689-63-4 | Olmesartan Medoxomil | 1190389-15-1 | Vibegron |
| 1632006-28-0 | Esaxerenone | 93-10-7 | Quinaldic acid | 7078-98-0 |
2,6-bis(1,1-dimethylethyl)-4- (phenylmethylene)-2, 5-cyclohexadien-1-one |
| Biocatalysis | |||||
(1-Cyano-2-ethoxy-2-oxoethylidenaminooxy)dimethylamino-morpholinocarbenium hexafluorophosphate (COMU) (CAS: 1075198-30-9) is a third-generation, highly efficient coupling reagent extensively utilized in advanced peptide synthesis. Based on the Oxyma scaffold, this premium uronium salt offers superior coupling performance comparable to HATU, while operating as a significantly safer, non-explosive alternative. It effectively minimizes racemization and ensures exceptionally high yields in amide bond formations. Manufactured under rigorous quality control, our industrial-grade COMU provides outstanding batch-to-batch consistency and high solubility, making it an indispensable intermediate for sophisticated active pharmaceutical ingredient (API) development.
Our hours
Public Account
IPv6 network supported
Technical Articles
